MANILA – The Philippine Health Insurance Corporation (PhilHealth) on Friday launched additional and expanded health benefit ...
Dialysis patients on denosumab (Prolia, Xgeva) had a lower risk for fracture but higher risk for a certain heart event, ...
Introduction The impact of sex on coronary artery disease prognosis is debated. It has been postulated that women receive ...
Flesch M, Hagemeister J, Berger HJ, et al.: Implementation of guidelines for the treatment of acute ST-elevation myocardial infarction: the Cologne Infarction Model Registry. Circ Cardiovasc ...
healthday on MSN4d
Six-Month Mortality Lower With Liberal Transfusion Strategy in Acute MI With AnemiaFor patients with acute myocardial infarction (MI) and anemia, the primary outcome of 30-day mortality or MI does not d ...
PhilHealth has significantly increased its coverage for Ischemic Heart Disease-Acute Myocardial Infarction (IHD-AMI) or ...
ACTICOR BIOTECH (FR0014005OJ5 - ALACT), a clinical stage biopharmaceutical company developing glenzocimab, an innovative drug ...
No dedicated clinical trials have compared denosumab and bisphosphonates for fracture prevention in patients on dialysis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback